Cargando…
Frontiers in mass spectrometry–based clinical proteomics for cancer diagnosis and treatment
Numerous omics studies, primarily genomics analyses, have been conducted to fully understand the molecular biological characteristics of cancer. In recent years, the depth of proteomic analysis, which comprehensively analyzes proteins and molecules that function directly in vivo, has increased drama...
Autores principales: | Haga, Yoshimi, Minegishi, Yuriko, Ueda, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154896/ https://www.ncbi.nlm.nih.gov/pubmed/36661476 http://dx.doi.org/10.1111/cas.15731 |
Ejemplares similares
-
Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations
por: Minegishi, Yuriko, et al.
Publicado: (2022) -
Fast and Ultrasensitive Glycoform Analysis by Supercritical
Fluid Chromatography–Tandem Mass Spectrometry
por: Haga, Yoshimi, et al.
Publicado: (2022) -
Mass spectrometry-based proteomics as an emerging tool in clinical laboratories
por: Birhanu, Alemayehu Godana
Publicado: (2023) -
Recent advances in mass spectrometry based clinical proteomics: applications to cancer research
por: Macklin, Andrew, et al.
Publicado: (2020) -
Mass Spectrometry–Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective
por: Qian, Liujia, et al.
Publicado: (2023)